Merck KGaA

In News

德國默克39億美元收購美國生物製藥公司SpringWorks(SWTX.US) - AASTOCKS.com

AASTOCKS.com - Apr 28, 2025

CSF-1R療法升溫！默克再斥8500萬美元取上海和譽候選藥全球權利 - 環球生技月刊

環球生技月刊 - Apr 02, 2025

市場報導：默克投資台灣5年170億台幣投入半導體前瞻材料研發 - 科技產業資訊室

科技產業資訊室 - Mar 27, 2025

生技｜德國默克集團想併購美國生技公司Springworks，搶攻癌症與罕見病領域的成長機遇！ - 優分析UAnalyze

優分析UAnalyze - Feb 11, 2025

默克砸 6 億美元，收購 Mirus Bio 進軍基因與細胞療法市場 - GeneOnline News

GeneOnline News - May 23, 2024

副總統接見德國默克集團( Merck KGaA )全球總裁暨執行長 Karl-Ludwig Kley - president.gov.tw

president.gov.tw - Mar 20, 2018

副總裁Yariv Hefez 百年製藥大廠如何內建「創新基因」! - 環球生技月刊

環球生技月刊 - Aug 26, 2024

LAN party! - Merck Group

Merck Group - Aug 08, 2018

蔡鴻青：兩家默克給台灣企業的啟示 - 財訊

財訊 - Mar 30, 2022

默克提出59億美元現金競購Versum - NAI500

NAI500 - Feb 28, 2019

看上細胞凋亡抑制蛋白抑制劑抗癌潛力？ Merck KGaA 從 Debiopharm 取得新藥授權 - GeneOnline News

GeneOnline News - Mar 02, 2021

台灣默克第11屆Taiwan BioForum：Smart Manufacturing and Integration of Biotechnologies: Accelerating Bioproc - 環球生技月刊

環球生技月刊 - Sep 20, 2024

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.